Matches in Wikidata for { <http://www.wikidata.org/entity/Q66064633> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q66064633 description "assaig clínic" @default.
- Q66064633 description "clinical trial" @default.
- Q66064633 description "clinical trial" @default.
- Q66064633 description "clinical trial" @default.
- Q66064633 description "clinical trial" @default.
- Q66064633 description "ensaio clínico" @default.
- Q66064633 description "ensayo clínico" @default.
- Q66064633 description "ensayu clínicu" @default.
- Q66064633 description "essai clinique" @default.
- Q66064633 description "klinisch onderzoek" @default.
- Q66064633 description "клінічне випробування" @default.
- Q66064633 name "A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain" @default.
- Q66064633 name "A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain" @default.
- Q66064633 type Item @default.
- Q66064633 label "A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain" @default.
- Q66064633 label "A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain" @default.
- Q66064633 prefLabel "A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain" @default.
- Q66064633 prefLabel "A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain" @default.
- Q66064633 P1050 Q66064633-2C9E53E0-BBD6-498D-9974-920C58C98C38 @default.
- Q66064633 P1132 Q66064633-7B8EC075-0F8B-4AAC-9E2F-0F8942A3EAF0 @default.
- Q66064633 P1476 Q66064633-87EAD478-5810-4FF9-AA44-D84326443B40 @default.
- Q66064633 P17 Q66064633-6C6B8ABC-3CB2-4C44-833E-A21DE744DC71 @default.
- Q66064633 P2899 Q66064633-E1820FEA-765E-44EC-8227-83FD92F5E833 @default.
- Q66064633 P3098 Q66064633-CEC0A3D3-54DC-4E5E-979B-87CAC561A93A @default.
- Q66064633 P31 Q66064633-76302920-09D0-49F4-93CE-7FA33D49BC79 @default.
- Q66064633 P4135 Q66064633-EF65B9FE-BB79-4D4D-8947-6A99984EE764 @default.
- Q66064633 P580 Q66064633-AF15AC22-99C4-45AA-B192-9270155EE400 @default.
- Q66064633 P582 Q66064633-D71A1440-38AF-462A-8B35-57A63130B37D @default.
- Q66064633 P6099 Q66064633-A5848C33-6684-4148-BF00-ED82FBB9974C @default.
- Q66064633 P8363 Q66064633-12822387-A7FF-47C6-85B5-F4B925B25B9C @default.
- Q66064633 P921 Q66064633-CADC699D-4B4D-4C40-B0A6-411F750D4ECB @default.
- Q66064633 P1050 Q205764 @default.
- Q66064633 P1132 "+450" @default.
- Q66064633 P1476 "A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Assess the Efficacy and Safety of Linzagolix in Subjects With Moderate to Severe Endometriosis-associated Pain." @default.
- Q66064633 P17 Q30 @default.
- Q66064633 P2899 "+18" @default.
- Q66064633 P3098 "NCT03986944" @default.
- Q66064633 P31 Q30612 @default.
- Q66064633 P4135 "+49" @default.
- Q66064633 P580 "2019-05-23T00:00:00Z" @default.
- Q66064633 P582 "2022-01-01T00:00:00Z" @default.
- Q66064633 P6099 Q42824827 @default.
- Q66064633 P8363 Q78089383 @default.
- Q66064633 P921 Q18554007 @default.